AIM Therapeutics Inc. Report issue

For profit Phase 2
Founded: Toronto ON Canada (2005)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2012
NCT01501942
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Ningbo Rongan Biological Pharmaceutical Co. Ltd | Ningbo Rongan Biological Pharmaceutical Co. Ltd.